However the observation that two-thirds continued to gain can be a finding that is key
- by Judy George, adding Writer, MedPage Today December 02, 2018
NEW ORLEANS — About one-third of patients who utilized cannabidiol (CBD) to control treatment-resistant epilepsy developed tolerance to it, scientists from Israel reported right here.
In a report of 92 kiddies and adults with treatment-resistant seizures whom utilized cannabis oil extract for an average of 19.8 months, tolerance to CBD emerged in 32.6% of clients, reported Shimrit Uliel-Sibony, MD, of Tel Aviv Sourasky Medical Center’s Dana Children’s Hospital, and peers during the American Epilepsy Society meeting that is annual. Continue reading…